Alterola Biotech, Inc.
Alterola Biotech, Inc. (ABTI) SEC Filings & 10-K Annual Reports
SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.
SEC EDGAR · data.sec.gov · CIK 0001442999 · ABTI · OTC · as of Jun 9, 2026
Filing snapshot
Source: SEC EDGAR (data.sec.gov) · CIK 0001442999 · Updated hourly · Not investment advice
Latest Annual Report
Latest Key Filings
No recent filings
Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.
SEC Filing History
About SEC Filings & 10-K Annual Reports
Alterola Biotech, Inc. (OTC: ABTI) has submitted 151 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2010. As a Healthcare sector company with CIK 0001442999, all filings are publicly accessible via the EDGAR database at no cost.
The annual 10-K report is Alterola Biotech, Inc.'s most comprehensive regulatory disclosure. The most recent Alterola Biotech, Inc. 10-K was filed on 2024-07-18 for fiscal year ending 2024. Historical ABTI 10-K annual reports are available from 2008 through 2024.
Investors researching Alterola Biotech, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.
Frequently Asked Questions
ABTI SEC Filings · 8 questionsAlterola Biotech, Inc. (ABTI) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 151 filings and access original documents at no cost. Alterola Biotech, Inc.'s CIK is 0001442999.